<?xml version="1.0" encoding="UTF-8"?>
<cas:metadata xmlns:cas="http://oodt.jpl.nasa.gov/1.0/cas">
<keyval type="vector">
<key>CAS.ProductId</key>
<val>bdc38f68-6a1d-11df-be96-f901d74aca33</val>
</keyval>
<keyval type="vector">
<key>ProductTitle</key>
<val>Incremental+AUC+values+contributed+by+an+eight-marker-plus-age+biomarker+panel+to+that+of+age+alone.</val>
<val>Incremental+AUC+values+contributed+by+an+eight-marker-plus-age+biomarker+panel+to+that+of+age+alone.</val>
</keyval>
<keyval type="vector">
<key>ProductDescription</key>
<val>Incremental+AUC+values+contributed+by+an+eight-marker-plus-age+biomarker+panel+to+that+of+age+alone.++%0A++The+AUCs+of+the+8-marker-plus-age+panels+in+the+3+models+were+higher+than+those+of+age+alone.+Overfitting-corrected+%0A++AUCs+remained+high%2C+and+increments+contributed+by+the+age-plus-biomarker+panel+versus+age+were+substantial+%0A++in+the+three+models.%0A++</val>
<val>Incremental+AUC+values+contributed+by+an+eight-marker-plus-age+biomarker+panel+to+that+of+age+alone.++%0A++The+AUCs+of+the+8-marker-plus-age+panels+in+the+3+models+were+higher+than+those+of+age+alone.+Overfitting-corrected+%0A++AUCs+remained+high%2C+and+increments+contributed+by+the+age-plus-biomarker+panel+versus+age+were+substantial+%0A++in+the+three+models.%0A++</val>
</keyval>
<keyval type="vector">
<key>SiteShortName</key>
<val>hkns</val>
</keyval>
<keyval type="vector">
<key>DateProductFrozen</key>
<val>N%2FA</val>
<val>N%2FA</val>
</keyval>
<keyval type="vector">
<key>Filename</key>
<val>Jin_Table2_IncrementalValues.doc</val>
</keyval>
<keyval type="vector">
<key>RecommendedSoftware</key>
<val>N%2FA</val>
</keyval>
<keyval type="vector">
<key>LabAnalyticMethods</key>
<val>One+hundred+ninety-five+Barrett%27s+Esophagus+%28BE%29+biopsies+%28145+nonprogressors+and+50+progressors%29+were+%0A++obtained+from+five+participating+centers%3A+the+Mayo+Clinic+at+Rochester%2FJacksonville%2C+the+University+of+Arizona%2C+%0A++the+University+of+North+Carolina%2C+and+Johns+Hopkins+University.+%0A++%0A++Bisulfite+treatment+was+performed+and+promoter+methylation+levels+of+8+genes+%28p16%2C+HPP1%2C+RUNX3%2C+CDH13%2C+TAC1%2C+NELL1%2C+%0A++AKAP12+and+SST%29+were+determined+by+qMSP+on+an+ABI+7900+Sequence+Detection+%28Taqman%29+System.+beta-+actin+was+used+for+%0A++normalization.+A+standard+curve+was+generated+using+serial+dilutions+of+CpGenome+Universal+Methylated+DNA+%28CHEMICON%2C+%0A++Temecula%2C+CA%29.+A+normalized+methylation+value+%28NMV%29+for+each+gene+of+interest+was+defined+as+described.%2811%29+Wetlab+%0A++analysts+%28ZJ+and+YC%29+and+all+SJM+laboratory+personnel+were+blinded+to+specimen+progressor+or+nonprogressor+status.%0A++</val>
<val>One+hundred+ninety-five+Barrett%27s+Esophagus+%28BE%29+biopsies+%28145+nonprogressors+and+50+progressors%29+were+%0A++obtained+from+five+participating+centers%3A+the+Mayo+Clinic+at+Rochester%2FJacksonville%2C+the+University+of+Arizona%2C+%0A++the+University+of+North+Carolina%2C+and+Johns+Hopkins+University.+%0A++%0A++Bisulfite+treatment+was+performed+and+promoter+methylation+levels+of+8+genes+%28p16%2C+HPP1%2C+RUNX3%2C+CDH13%2C+TAC1%2C+NELL1%2C+%0A++AKAP12+and+SST%29+were+determined+by+qMSP+on+an+ABI+7900+Sequence+Detection+%28Taqman%29+System.+beta-+actin+was+used+for+%0A++normalization.+A+standard+curve+was+generated+using+serial+dilutions+of+CpGenome+Universal+Methylated+DNA+%28CHEMICON%2C+%0A++Temecula%2C+CA%29.+A+normalized+methylation+value+%28NMV%29+for+each+gene+of+interest+was+defined+as+described.%2811%29+Wetlab+%0A++analysts+%28ZJ+and+YC%29+and+all+SJM+laboratory+personnel+were+blinded+to+specimen+progressor+or+nonprogressor+status.%0A++</val>
</keyval>
<keyval type="vector">
<key>DataStage</key>
<val>Processed</val>
<val>Processed</val>
</keyval>
<keyval type="vector">
<key>CAS.ProductName</key>
<val>Jin_Table2_IncrementalValues.doc</val>
</keyval>
<keyval type="vector">
<key>ProductType</key>
<val>HopkinsMeltzerBarrettMethylationProfiles</val>
</keyval>
<keyval type="vector">
<key>ProductFunction</key>
<val>AUC+and+confidence+intervals+presented%0A++</val>
<val>AUC+and+confidence+intervals+presented%0A++</val>
</keyval>
<keyval type="vector">
<key>FileLocation</key>
<val>%2Fdata%2Fingest%2Fbarrett%2Ft2incremental</val>
</keyval>
<keyval type="vector">
<key>InstrumentDetails</key>
<val>N%2FA</val>
<val>N%2FA</val>
</keyval>
<keyval type="vector">
<key>MethodDetails</key>
<val>Associations+between+progression+status+and+patient+characteristics+were+tested+using+Student%27s+t-test+or+%0A++Chi-squared+testing.+Relationships+between+biomarkers+and+patient+progression+status+were+examined+using+Wilcoxon+%0A++rank-sum+testing.%0A++%0A++To+evaluate+the+predictive+utility+of+the+markers%2C+we+constructed+receiver+operating+characteristic+%28ROC%29+curves.+%0A++ROC+curve+analyses+were+first+conducted+on+individual+markers%2C+then+in+combination+to+determine+whether+a+panel+performed+%0A++better+than+any+single+marker.+Our+algorithm+rendered+a+single+composite+score%2C+using+the+linear+predictor+from+a+binary+%0A++regression+model+justified+under+the+linearity+assumption.+The+predictive+accuracy+of+composite+scores+was+evaluated+based+%0A++on+a+resampling+algorithm%3A+we+randomly+split+data+into+a+learning+set+containing+2%2F3+and+a+test+set+including+1%2F3+of+%0A++observations.+The+combination+rule+derived+from+the+learning+set+produced+two+ROC+curves%2C+from+the+learning+and+test+sets%2C+%0A++respectively.+Vertical+differences+between+these+two+ROC+curves+yielded+the+overestimation+of+sensitivities+at+given+%0A++specificities.+This+procedure+was+repeated+200+times%2C+and+these+200+differences+were+averaged+to+estimate+the+expected+%0A++overfitting.%0A++%0A++We+also+utilized+predictiveness+curves+to+display+risk+distribution+as+a+function+of+the+combined+marker+in+the+population.+%0A++This+curve+represents+a+plot+of+risk+associated+with+the+vth+quantile+of+the+marker%2C+P%7BD%3D1%7CY+%3DF-1%28v%29%7D+vs.+v%2C+with+F%28.%29+the+%0A++cumulative+distribution+of+the+marker.+These+plots+display+population+proportions+at+different+risk+levels+more+clearly+than+%0A++do+other+metrics+%28like+ROC+curves%29.+Since+a+case-control+sample+was+studied%2C+we+used+an+external+progression+prevalence+rate+%0A++to+calculate+risk+in+the+targeted+screening+population.+To+calibrate+for+future+samples%2C+a+shrinkage+coefficient+estimated+from+%0A++the+logistic+regression+model+was+applied+to+the+linear+predictors+from+which+risk+was+calculated.+%0A++%0A++All+analyses+were+performed+in+R+%28http%3A%2F%2Fwww.r-project.org%29.+Statistical+data+analysts+%28Y.Z.%2C+W.G.%2C+and+Z.F.%29+were+blinded+to+%0A++the+identities+of+the+8+biomarkers.%0A++</val>
<val>Associations+between+progression+status+and+patient+characteristics+were+tested+using+Student%27s+t-test+or+%0A++Chi-squared+testing.+Relationships+between+biomarkers+and+patient+progression+status+were+examined+using+Wilcoxon+%0A++rank-sum+testing.%0A++%0A++To+evaluate+the+predictive+utility+of+the+markers%2C+we+constructed+receiver+operating+characteristic+%28ROC%29+curves.+%0A++ROC+curve+analyses+were+first+conducted+on+individual+markers%2C+then+in+combination+to+determine+whether+a+panel+performed+%0A++better+than+any+single+marker.+Our+algorithm+rendered+a+single+composite+score%2C+using+the+linear+predictor+from+a+binary+%0A++regression+model+justified+under+the+linearity+assumption.+The+predictive+accuracy+of+composite+scores+was+evaluated+based+%0A++on+a+resampling+algorithm%3A+we+randomly+split+data+into+a+learning+set+containing+2%2F3+and+a+test+set+including+1%2F3+of+%0A++observations.+The+combination+rule+derived+from+the+learning+set+produced+two+ROC+curves%2C+from+the+learning+and+test+sets%2C+%0A++respectively.+Vertical+differences+between+these+two+ROC+curves+yielded+the+overestimation+of+sensitivities+at+given+%0A++specificities.+This+procedure+was+repeated+200+times%2C+and+these+200+differences+were+averaged+to+estimate+the+expected+%0A++overfitting.%0A++%0A++We+also+utilized+predictiveness+curves+to+display+risk+distribution+as+a+function+of+the+combined+marker+in+the+population.+%0A++This+curve+represents+a+plot+of+risk+associated+with+the+vth+quantile+of+the+marker%2C+P%7BD%3D1%7CY+%3DF-1%28v%29%7D+vs.+v%2C+with+F%28.%29+the+%0A++cumulative+distribution+of+the+marker.+These+plots+display+population+proportions+at+different+risk+levels+more+clearly+than+%0A++do+other+metrics+%28like+ROC+curves%29.+Since+a+case-control+sample+was+studied%2C+we+used+an+external+progression+prevalence+rate+%0A++to+calculate+risk+in+the+targeted+screening+population.+To+calibrate+for+future+samples%2C+a+shrinkage+coefficient+estimated+from+%0A++the+logistic+regression+model+was+applied+to+the+linear+predictors+from+which+risk+was+calculated.+%0A++%0A++All+analyses+were+performed+in+R+%28http%3A%2F%2Fwww.r-project.org%29.+Statistical+data+analysts+%28Y.Z.%2C+W.G.%2C+and+Z.F.%29+were+blinded+to+%0A++the+identities+of+the+8+biomarkers.%0A++</val>
</keyval>
<keyval type="vector">
<key>CAS.ProductReceivedTime</key>
<val>2010-05-27T22%3A56%3A21.472-07%3A00</val>
</keyval>
<keyval type="vector">
<key>SpecimenType</key>
<val>Tissue+biopsy</val>
<val>Tissue+biopsy</val>
</keyval>
</cas:metadata>
